Pharma Regulatory Affairs Consulting Services in India
Artixio provides end-to-end pharmaceuticals regulatory affairs support in India, including strategic consulting, international product registration, regulatory process management, and post-marketing compliance services.
Services We Offer
Pharmaceuticals Regulatory Agency and CDSCO Approval Guidance
With over three decades of specialized experience, Artixio has helped more than 50 global pharmaceutical companies enter the Indian market. Through practical pharma regulatory affairs strategies in India and a focus on results, we guide companies through complex processes and support them in reaching their commercial goals.
Artixio provides complete pharmaceuticals regulatory affairs consulting services in India. We support pharma companies from early development to post-approval maintenance. Our Highly experienced consultant team helps with strategic advice, regulatory writing, dossier preparation, labeling, promotional material review, and regulatory information management. With the right mix of experience and regulatory insight, we make it easier for your pharmaceutical product to stay regulatory compliant and move forward confidently in the Indian market.
Regulatory Support for CDSCO Compliance and Indian Market Access
Classification of Pharmaceuticals in India
CDSCO regulates drug registration in India under the Drugs and Cosmetics Act. Manufacturers and importers must apply through Form 44 and pay the applicable fees. The pharma regulatory affairs approval process in India includes dossier preparation, technical review, and coordination with authorities to move the application forward.
Types of Licenses under CDSCO
CDSCO offers various drug licence types in India, depending on the product and stage. Artixio offers pharma regulatory support across all stages of drug development and approval. With deep expertise in drug regulatory affairs in India, we help pharmaceutical companies meet CDSCO licensing requirements efficiently and compliantly.
Cost for Pharmaceuticals License in India
| License Type | Cost |
|---|---|
| Retail | INR 45,000 |
| Wholesale | INR 40,000 |
| Manufacturing | INR 1,00,000 |
Pharma Regulatory Affairs Process in India
Getting approvals in India isn’t just about forms — it’s about knowing how CDSCO works.
As a pharmaceutical regulatory services company, we help simplify every step for you. Here are the steps for registering a drug product in India:
Preparation phase
- The pharmaceutical product intended for registration must be clearly identified, with a comprehensive understanding of its therapeutic value and regulatory requirements.
- The required documents, formulation and manufacturing details, stability data should be ready for submission.
Application submission to CDSCO
- The dossier should be submitted to CDSCO in the CTD (common technical document) format for a NDA or ANDA application
- Application have to be submitted via online portal and fees have to be paid along with submission of required documents.
Evaluation by the CDSCO
- The application will go through the screening process to make sure its completeness.
- The application will be thoroughly reviewed for its safety, efficacy and quality data.
- The CDSCO will also conduct GMP inspections.
Approval of the application
- Upon thorough evaluation and satisfaction of the Central Drugs Standard Control Organisation (CDSCO), approval is granted for the drug's market entry.
Regulatory Process for Pharmaceuticals in India
End-to-End Regulatory Support for Entering the Indian Market
Timeline
It takes approximately 9 months to get the drug product approval for the import license in India. It takes 180 days for new drug registration and around approx. 3 months for registration of cosmetic product.
Labelling requirements
- Drug product name
- Net content (in weight/volume/number of units)
- Active ingredients
- Name and address of the manufacturer
- Batch number
- Any special precaution or remark
Post-Marketing Surveillance
- Adverse drug reactions reporting
- Pharmacovigilance programme of India
- Signal detection and analysis
- Periodic safety Update reports (PSUR’s)
- Risk evaluation and mitigation strategies
- Medical & Technical Writing
- Due Diligence and Gap Analysis
- Dossier Preparation and compilation
- Dossier Publishing & Submission
- Product Registration
- Marketing Authorization Holder (MAH/LR)
- Investigation New Drug Application (IND) / Clinical Trial Application (CTA)
- New Drug Application (NDA) / Marketing Authorization Applications (MAA)
- Post Approval Lifecycle Maintenance
- Artwork and Label Review
- Ad Promo Review
- Distributor and Import Assistance
Collaborate with Artixio’s Indian Expertise for Seamless Global Delivery
- Successful Approvals and Product Lifecycle Maintenance for 300+ products
- Diverse Products Experience across Complex Products Categories and Therapeutic Areas
- Strong Regional Expert with 30+ years of experience
- Proven Experience in End-to-End Product Value Chain from Concept to Commercialization
- Health Authority Experience in Navigating through Complex, often Ambiguous Regulations
- ISO 9001:2015 quality standards governed services
- Customer focused, flexible services and solutions
- Flexible Business Model including project based, managed services and FTE staffing model
- Hybrid-Local-Centralized Support across Regulatory functions
FAQs
1. What is the validity of drug registration?
2. In India, what are the requirements for clinical trial?
3. What are the requirement for importing drugs to India?
4. When is the re-registration or renewal is done?
5. What are some of the main responsibilities of CDSCO?
Still Have Questions ?
Specialized Regulatory Affairs
Services Across Multiple Industries
Pharmaceuticals
MedTech
Cosmetics
Nutrition
Biologics
Veterinary
Related India Services
Regulatory Affairs Across Multiple Countries
India
Singapore
Mexico
Brazil
Vietnam
Malaysia
Argentina
Colombia
Taiwan
China
European
Thailand
Indonesia
Philippines
USA
Japan
Qatar
South Korea
Insights from Artixio - Tips & Articles
CDSCO Simplifies Subsequent Importer
India’s regulatory authority, the Central Drugs Standard Control Organization (CDSCO), has published an important...
CDSCO Medical Device Approval
Central Drug Standard Control Organization (CDSCO) is the regulatory authority that regulates Medical Devices...
IVD Medical Devices Registration
IVDs in India are regulated as drugs under Section 3(b)(i) and 3(b)(iv) of the...